Telemus Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Telemus Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,000	Closed	-$272K	–	430
2019 Q1	$272K	Hold	3,000	–	–	0.02%	351
2018 Q4	$215K	Sell	3,000 -2,150	-42%	-$173K	0.02%	379
2018 Q3	$494K	Hold	5,150	–	–	0.04%	289
2018 Q2	$490K	Buy	5,150 +2,150	+72%	+$198K	0.04%	297
2018 Q1	$263K	Hold	3,000	–	–	0.02%	369
2017 Q4	$255K	Hold	3,000	–	–	0.02%	378
2017 Q3	$260K	Hold	3,000	–	–	0.03%	290
2017 Q2	$232K	Buy	+3,000	New	+$213K	0.02%	326

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Telemus Capital's XBI Position: Q2 2019 in Review

Telemus Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2019, closing a stake of 3,000 shares — an estimated $272K sold.

Telemus Capital first reported a position in XBI in Q2 2017 and held it in 8 quarters. The position peaked at $494K in Q3 2018. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.

Telemus Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2019 after selling out during the quarter.
Telemus Capital sold 3,000 State Street SPDR S&P Biotech ETF shares in Q2 2019, an estimated $272K.
Telemus Capital first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and held it in 8 quarters.
Telemus Capital's State Street SPDR S&P Biotech ETF position peaked at $494K in Q3 2018.
424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.

Based on Telemus Capital's 13F filing for Q2 2019, filed 9 Aug 2019.